摘要
目的探讨肺结核合并肝硬化患者的抗结核治疗。方法回顾分析我院住院肺结核合并肝硬化患者20例,按肝硬化情况分为两组:代偿期组和失代偿期组,代偿期组予HRTEO,失代偿期组予HAKEO,两组患者在抗结核治疗同时均予积极护肝治疗,密切监测肝功。结果 20例肺结核合并肝硬化患者抗结核治疗总好转率85%,仅1例死亡。结论肺结核合并肝硬化患者选择合适的抗结核治疗方案,可获得良好的治疗效果。
Objectve To study the anti-tuberculosis therapeutic effect on patients with pulmonary tuberculosis complicated with liver cirrhoss. Methods 20 cases of pulmonary tuberculosis complicated with liver cirrhoss were studied. The patients were divided into two groups according to the condition of liver cirrhosis ： the compensation phase group and the un-compensation phase group. The former was treated with HRTEO, and the latter was treated with HAKEO. At the same time, the two groups were given the protective-liver treat- ment, monitoring liver function exactly. Results The improvement rate of 20 cases of pulmonary tuberculosis with liver cirrhoss was 85% , only 1 case of deaths. Conclusion Choosing suitable treatment program, the antl-tuberculosls treatment of patients with pulmonary tuber- culosis with liver cirrhosis can be effective.
出处
《临床肺科杂志》
2012年第9期1631-1632,共2页
Journal of Clinical Pulmonary Medicine
关键词
肺结核
肝硬化
pulmonary tuberculosis
liver cirrhosis
